Catalog No. |
TD-JN998016 |
Species reactivity |
Staphylococcus aureus |
Applications |
Research Grade Biosimilar |
Host species |
Human |
Isotype |
IgG1-lambda |
Expression system |
Mammalian Cells |
Clonality |
Monoclonal |
Target |
Alpha-hemolysin, hly, Alpha-HL, Alpha-toxin, hla |
Endotoxin level |
Please contact the lab for this information. |
Purity |
>95% purity as determined by SDS-PAGE. |
Purification |
Protein A/G, purified from cell culture supernatant. |
Accession |
P09616 |
Form |
Liquid |
Storage buffer |
0.01M PBS,pH7.4. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
Alternate Names |
KBSA301,CAS:1374419-41-6 |
Background |
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent. |
Note |
For research use only. Not for use in clinical or therapeutic applications. |